The comparison of the antihypertensive efficacy and tolerability between valsartan plus hydrochlorothiazide 80mg/12.5mg and amlodipine 5mg in the essential hypertensive patients
Phase of Trial: Phase IV
Latest Information Update: 21 Aug 2008
At a glance
- Drugs Amlodipine; Valsartan/hydrochlorothiazide
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 21 Aug 2008 Actual end date (Sep 2007) added as reported by ClinicalTrials.gov.
- 21 Aug 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Sep 2007 Status changed from recruiting to in progress.